YMTracker DRIPCalc v2 Launch sale

NEW Dividend Portfolio Tracker (DRIPTracker) is Now Live!

Add your stocks and see every dividend they pay you — dates, amounts, and reinvested shares.

OMCL | NASDAQ

$35.82 $0.99 | 2.84%

TREND SIGNAL: Signal available — unlock to view

Signal available — unlock to view

|2026-10-07

Add to favoritesFavorite

Company Overview:

Market Cap: $1.63B

Trailing PE: 42.6x

FWD PE *: 19.9x

Payout Ratio (TTM): —

52-Week Range: $29.06 - $55.00

* Forward PE is based on street estimates.

10 Year OMCL Performance Metrics:

Total Return (with DRIP): -1.7% (-0.17% CAGR)

Total Return (no DRIP): -1.7% (-0.17% CAGR)

Share Price: -1.7% (-0.17% CAGR)

Yield on Cost (with DRIP): —

Total Invested: $10,000

Total Value (with DRIP): $9,827

Total Return $ (with DRIP): -$173

OMCL Total Return

1M 3M 6M YTD 1Y 3Y 5Y 10Y

OMCL Price Chart

1M 3M 6M YTD 1Y 3Y 5Y 10Y All

Unlock All Reports & Research Dividend Stocks like a BOSS!

Get 3 Months Free with Annual Plan

PRO

$171 ($14.25/mo) $102.60/yr ($8.55/mo)

7-day free trial

Unlimited Portfolio Tracker
Portfolio - Lots/Sales/Dividends
Portfolio Auto-DRIP
Buy/Sell Signals Dashboard
Stock Fundamentals
Compare Stocks Side-by-Side
Revenue & EPS Estimates
DCF Valuation Modeling

Try it free for 7 days

Combined 55% Lifetime Discount

Most Popular

PREMIUM

$288 ($24/mo) $172.80/yr ($14.40/mo)

7-day free trial

Everything in Pro
YieldMax PNL Tracker
YieldMax NAV Erosion Alerts
YM ETFs Trend Signals
9/21 EMA Trend Signals
Stocks Dashboard

Try it free for 7 days

Combined 55% Lifetime Discount

ULTRA

$576 ($48/mo) $345.60/yr ($28.80/mo)

7-day free trial

Everything in Premium
15min & 1hr Intraday Signals
Group & weekly ETF estimates
YouTuber Mode
Trades summary + CSV export
Priority data & support

Try it free for 7 days

Combined 55% Lifetime Discount

OMCL Financials: Earnings, Revenue, Cash Flow, Ebitda, Cash/Debt, Shares Float, etc:

OMCL - Revenue

OMCL Revenue CAGR:1Y: 7.45%2Y: 6.21%5Y: 2.74%10Y: 6.09%

OMCL - Earnings Per Share (EPS)

OMCL EPS CAGR:1Y: 333.33%2Y: 153.22%5Y: 3.87%10Y: 0.00%

OMCL - Net Income

🔓 See the full chart40% off right now · 7-day free trial

OMCL Net Income CAGR:1Y: 330.73%2Y: 155.01%5Y: 3.53%10Y: 0.00%

OMCL - EBITDA

🔓 See the full chart40% off right now · 7-day free trial

OMCL EBITDA CAGR:1Y: 63.94%2Y: 28.65%5Y: 4.23%10Y: 13.80%

OMCL - Free Cash Flow

🔓 See the full chart40% off right now · 7-day free trial

OMCL Free Cash Flow CAGR:1Y: 80.10%2Y: 11.15%5Y: -3.25%10Y: 0.00%

OMCL - Free Cash Flow / Share

🔓 See the full chart40% off right now · 7-day free trial

OMCL Free Cash Flow / Share CAGR:1Y: 101.35%2Y: 16.48%5Y: -2.60%10Y: 0.00%

OMCL - Operating Income

🔓 See the full chart40% off right now · 7-day free trial

OMCL Operating Income CAGR:1Y: 299.62%2Y: 217.25%5Y: 2.33%10Y: 0.00%

OMCL - Gross Profit

🔓 See the full chart40% off right now · 7-day free trial

OMCL Gross Profit CAGR:1Y: 19.78%2Y: 15.65%5Y: 2.33%10Y: 6.96%

OMCL - Shares Outstanding

🔓 See the full chart40% off right now · 7-day free trial

OMCL Shares Outstanding CAGR:1Y: -1.46%2Y: 0.29%5Y: -0.34%10Y: 2.55%

OMCL - Share Buybacks

🔓 See the full chart40% off right now · 7-day free trial

OMCL Share Buybacks CAGR:1Y: -97.52%2Y: 0.00%5Y: 0.00%10Y: -10.53%

OMCL - Stock-Based Comp

🔓 See the full chart40% off right now · 7-day free trial

OMCL Stock-Based Comp CAGR:1Y: 15.93%2Y: 10.31%5Y: -1.31%10Y: 8.31%

OMCL - Expenses

🔓 See the full chart40% off right now · 7-day free trial

OMCL Expenses CAGR:1Y: -24.12%2Y: -18.77%5Y: 8.38%10Y: 5.17%

OMCL - Revenue vs Net Income

🔓 See the full chart40% off right now · 7-day free trial

OMCL - EPS vs FCF / Share

🔓 See the full chart40% off right now · 7-day free trial

OMCL - EPS vs PE Ratio

🔓 See the full chart40% off right now · 7-day free trial

OMCL - FCF vs FCF / Share

🔓 See the full chart40% off right now · 7-day free trial

OMCL - FCF vs Stock Based Comp

🔓 See the full chart40% off right now · 7-day free trial

OMCL - Cash & Debt

🔓 See the full chart40% off right now · 7-day free trial

OMCL - Revenue by Segment

🔓 See the full chart40% off right now · 7-day free trial

OMCL Revenue CAGR:1Y: 7.45%2Y: 6.21%5Y: 2.74%10Y: 6.09%

OMCL - Revenue by Region

🔓 See the full chart40% off right now · 7-day free trial

OMCL Revenue CAGR:1Y: 7.45%2Y: 6.21%5Y: 2.74%10Y: 6.09%

Revenue, EPS, Net Income & Ebitda - Estimates VS Actual:

OMCL - REVENUE: Actual + Estimates

🔓 See the full chart40% off right now · 7-day free trial

OMCL Actual Revenue CAGR:1Y: 7.45%2Y: 6.21%5Y: 2.74%10Y: 6.09%

OMCL - EPS: Actual + Estimates

🔓 See the full chart40% off right now · 7-day free trial

OMCL Actual EPS CAGR:1Y: 333.33%2Y: 153.22%5Y: 3.87%10Y: 0.00%

OMCL - NET INCOME: Actual + Estimates

🔓 See the full chart40% off right now · 7-day free trial

OMCL Actual Net Income CAGR:1Y: 330.73%2Y: 155.01%5Y: 3.53%10Y: 0.00%

OMCL - EBITDA: Actual + Estimates

🔓 See the full chart40% off right now · 7-day free trial

OMCL Actual EBITDA CAGR:1Y: 63.94%2Y: 28.65%5Y: 4.23%10Y: 13.80%

Ratios, Profit Margins & Return on Capital:

OMCL - Net Profit Margin

🔓 See the full chart40% off right now · 7-day free trial

OMCL Net Profit Margin CAGR:1Y: 301.03%2Y: 140.06%5Y: 0.76%10Y: 0.00%

OMCL - Gross Profit Margin

🔓 See the full chart40% off right now · 7-day free trial

OMCL Gross Profit Margin CAGR:1Y: 11.47%2Y: 8.89%5Y: -0.40%10Y: 0.82%

OMCL - Price to Earnings

🔓 See the full chart40% off right now · 7-day free trial

OMCL Price to Earnings CAGR:1Y: -68.02%2Y: -51.11%5Y: -24.64%10Y: 0.00%

OMCL - Price To Sales Ratio

🔓 See the full chart40% off right now · 7-day free trial

OMCL Price To Sales Ratio CAGR:1Y: 27.72%2Y: 16.90%5Y: -24.11%10Y: -1.63%

OMCL - Return on Capital Employed

🔓 See the full chart40% off right now · 7-day free trial

OMCL Return on Capital Employed CAGR:1Y: 299.54%2Y: 249.65%5Y: 3.52%10Y: 0.00%

OMCL - Return on Invested Capital

🔓 See the full chart40% off right now · 7-day free trial

OMCL Return on Invested Capital CAGR:1Y: 491.31%2Y: 338.49%5Y: -0.82%10Y: 0.00%

Projected Future Returns & Dividends for OMCL

Based on past 10-year performance, here are OMCL growth metrics:

Share price CAGR of -0.35%
Dividend CAGR of +0%

Using OMCL CAGR metrics, we can estimate that your initial $10000 investment, over the next 10 years, should grow as follows:

	OMCL (DRIP)	OMCL - No DRIP
Current Price	$35.82	$35.82
Start Shares	279.17	279.17
Start Value	$10,000	$10,000

After 10 years:
Final Share Count	279.17	279.17
Dividends Payment	$0.00	$0.00
Annual Dividends	$0	$0
Yield on cost	0.00%	0.00%
Share Price	$34.58	$35.82
Total Dividends	$0	$0
Final Value	$9,655	$10,000

Estimated Future Value + Dividends - OMCL

NOTE: Above numbers are our estimate based on OMCL's Dividend and Price CAGR over past 10 years. These numbers should only be considered as "potential future returns"! DRIP assumes reinvesting dividends; No-DRIP assumes collecting dividends as cash.

We cannot guarantee that your actual returns will meet these estimates.

Get the best Dividend Stock Research Tools:

Get 3 Months Free with Annual Plan

PRO

$171 ($14.25/mo) $102.60/yr ($8.55/mo)

7-day free trial

Unlimited Portfolio Tracker
Portfolio - Lots/Sales/Dividends
Portfolio Auto-DRIP
Buy/Sell Signals Dashboard
Stock Fundamentals
Compare Stocks Side-by-Side
Revenue & EPS Estimates
DCF Valuation Modeling

Try it free for 7 days

Combined 55% Lifetime Discount

Most Popular

PREMIUM

$288 ($24/mo) $172.80/yr ($14.40/mo)

7-day free trial

Everything in Pro
YieldMax PNL Tracker
YieldMax NAV Erosion Alerts
YM ETFs Trend Signals
9/21 EMA Trend Signals
Stocks Dashboard

Try it free for 7 days

Combined 55% Lifetime Discount

ULTRA

$576 ($48/mo) $345.60/yr ($28.80/mo)

7-day free trial

Everything in Premium
15min & 1hr Intraday Signals
Group & weekly ETF estimates
YouTuber Mode
Trades summary + CSV export
Priority data & support

Try it free for 7 days

Combined 55% Lifetime Discount

Company Info

Omnicell, Inc. (OMCL) had its IPO on 2001-08-07, and is traded on NASDAQ stock exchange.

Omnicell, Inc., together with its subsidiaries, provides healthcare technology in the United States and internationally. It offers hospital and health systems solutions, such as points of care for clinician workflows in patient care areas of the healthcare system; Titan XT, an automated dispensing system; XTExtend, a console swap for its XT cabinets; and Central Pharmacy Dispensing Service for the medication dispensing process. The company also provides Central Med Automation Service for medication dispensing; IV Compounding Service, an in-house compounding system; specialty pharmacy services, including turnkey solution to help health systems establish, manage, and optimize an entity-owned specialty pharmacy; EnlivenHealth platform to digitally enable retail and community pharmacies; medication adherence solutions comprising consumables and medication packaging systems; and technology implementation, customer education and training, program management, and related offerings to professional services. In addition, it offers post-installation support and maintenance via phone and/or web, on-site service, parts, and access to software upgrades; software and hardware products for full traceability of medicines and medical supplies throughout the healthcare system; OmniSphere, a cloud-based platform. The company was formerly known as Omnicell Technologies, Inc. and changed its name to Omnicell, Inc. in 2001. Omnicell, Inc. was incorporated in 1992 and is headquartered in Fort Worth, Texas.

OMCL website: https://www.omnicell.com

Get Full Access to All Reports with DRIPCalc PRO

Get 3 Months Free with Annual Plan

PRO

$171 ($14.25/mo) $102.60/yr ($8.55/mo)

7-day free trial

Unlimited Portfolio Tracker
Portfolio - Lots/Sales/Dividends
Portfolio Auto-DRIP
Buy/Sell Signals Dashboard
Stock Fundamentals
Compare Stocks Side-by-Side
Revenue & EPS Estimates
DCF Valuation Modeling

Try it free for 7 days

Combined 55% Lifetime Discount

Most Popular

PREMIUM

$288 ($24/mo) $172.80/yr ($14.40/mo)

7-day free trial

Everything in Pro
YieldMax PNL Tracker
YieldMax NAV Erosion Alerts
YM ETFs Trend Signals
9/21 EMA Trend Signals
Stocks Dashboard

Try it free for 7 days

Combined 55% Lifetime Discount

ULTRA

$576 ($48/mo) $345.60/yr ($28.80/mo)

7-day free trial

Everything in Premium
15min & 1hr Intraday Signals
Group & weekly ETF estimates
YouTuber Mode
Trades summary + CSV export
Priority data & support

Try it free for 7 days

Combined 55% Lifetime Discount

Loading signals…

DCF Model — OMCL

Value from:

EPS (TTM)icompany profit per share over the last 12 months

EPS Growth %ihow fast profit per share grows each of the next 5 years — prefilled with what analysts expect

EPS growth after year 5 (forever)ithe slower pace once the fast 5 years are over — only drives years 6-10 of the price path below

Exit multiple (PE in 5 yrs)iwhat buyers pay per $1 of profit in 2031 — prefilled with today’s forward PE

Desired return %/yrithe yearly return you want from buying today — the S&P has done ~14%/yr, ask for more from a single stock

FCF growth %/yr (next 5 yrs)ihow fast free cash flow grows while the company is still expanding fast

Years of fast FCF growthihow many years the fast growth lasts before the business settles down

FCF growth after year 5 (forever)ithe slow, steady pace once the company is mature — usually 2-3%, near inflation. Must stay below your target return

Risk-free rate %iwhat a 10-yr US treasury pays with zero risk — the floor any risky stock must beat

Your target return %/yrithe yearly return you want for taking this risk — rule of thumb: risk-free rate + extra for risk

FCF base ($M, TTM)ilast 12 months of free cash flow, added up from reported quarters

Include dividends in returnidividends hand you part of the return in cash, so the share price needs to climb less

Pay up to today

—

vs current price $35.82

—

Cash flow & implied price by year

FCF is negative or missing for this company (common for banks) — the model discounts EPS instead.

EPS is negative or missing for this company — Simple mode uses free cash flow per share instead.

Free cash flow today

—

grows for the next years

Then mature

—

every future dollar counted back to today

Pile of today-dollars

—

÷ shares

Implied price path

Year	FCF	Implied price

Sensitivity — fair value: growth ↓ × target return →

× Free Portfolio Tracker

Own OMCL? See every dividend it's paid you

Add your OMCL shares to a free account and every payment you've received is listed — dated, in dollars — with reinvested shares counted and monthly totals. Room for 4 more stocks.

✓Every OMCL dividend you've received, dated, with the amount
✓Reinvested (DRIP) shares counted for you
✓Monthly totals across up to 5 stocks

Add OMCL free →

Free plan · up to 5 holdings